Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc. demonstrated robust financial performance, highlighted by a 27.3% year-over-year revenue growth in its Home Health & Hospice segment, reaching $69.3 million, with gross margins slightly exceeding targeted ranges. The Medical Solutions segment also reported a significant 21.3% revenue increase to $52.5 million, coupled with a gross margin expansion of 570 basis points to 50.0%, benefiting from improved cash collections. Furthermore, the Private Duty Services segment achieved an impressive 28.1% revenue growth year-over-year, driven by successful volume and rate increases, with strong performance further supported by the integration of the Thrive acquisition.

Bears say

Aveanna Healthcare Holdings Inc. is facing fundamental challenges that suggest a negative outlook for the stock. The reported decline in the Private Duty Nursing (PDN) spread rate from $12.60 to $12.12 indicates ongoing wage pressures that could erode profitability. Additionally, the company is dealing with significant headwinds, including reimbursement pressures, high leverage, and increasing competition, which are projected to contribute to a 10% downside to adjusted EBITDA estimates for fiscal years 2026 and 2027.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.